Hypertensive kidney disease: a true epidemic or rare disease?
- PMID: 31964856
- DOI: 10.20452/pamw.15150
Hypertensive kidney disease: a true epidemic or rare disease?
Abstract
In the industrialized world, hypertension affects approximately 30% of the general population. Hypertensive kidney disease is considered one of the consequences of long-term and poorly controlled hypertension. According to renal databases, it is a leading cause of end‑stage renal failure, second only to diabetic kidney disease. We challenge this dogma by emphasizing lack of specificity of both clinical and morphological presentations of hypertension‑related kidney disease and very low prevalence of hypertensive kidney disease that is diagnosed based on kidney biopsy findings in registries. In most cases of concomitant hypertension and chronic kidney disease (CKD), the sequence of events (ie, which came first, CKD or hypertension) cannot be established. Arterial hypertension plays a role in the pathogenesis of chronic vascular disease and may occasionally lead to arterionephrosclerosis, but its general significance in the evolution of CKD and prevalence among CKD patients appear to be highly overestimated. Studies of the morphology of kidney biopsies have indicated that arterionephrosclerosis, classically considered a morphological equivalent of the clinical term "hypertensive kidney disease"(previously referred to as "hypertensive nephropathy"), most commonly superimposes upon variable chronic renal diseases, even in the absence of elevated blood pressure. To date, no prospective controlled clinical trials have been conducted in primary hypertension patients with renal events as primary endpoints. Data from available clinical trials with renal events that serve as secondary endpoints suggest that lowering blood pressure below current targets may provide additional cardiovascular benefits but may be harmful to the kidneys.
Similar articles
-
Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.Adv Exp Med Biol. 2017;956:279-306. doi: 10.1007/5584_2016_85. Adv Exp Med Biol. 2017. PMID: 27873229 Review.
-
[Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].Srp Arh Celok Lek. 2002 Mar-Apr;130(3-4):73-80. doi: 10.2298/sarh0204073j. Srp Arh Celok Lek. 2002. PMID: 12154518 Serbian.
-
Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.J Hypertens. 2012 Dec;30(12):2378-86. doi: 10.1097/HJH.0b013e328359b6a9. J Hypertens. 2012. PMID: 23137952
-
Combined Association of Serum Uric Acid and Metabolic Syndrome with Chronic Kidney Disease in Hypertensive Patients.Kidney Blood Press Res. 2016;41(4):413-23. doi: 10.1159/000443443. Epub 2016 Jun 30. Kidney Blood Press Res. 2016. PMID: 27355680
-
CKD in China: Evolving Spectrum and Public Health Implications.Am J Kidney Dis. 2020 Aug;76(2):258-264. doi: 10.1053/j.ajkd.2019.05.032. Epub 2019 Sep 3. Am J Kidney Dis. 2020. PMID: 31492486 Review.
Cited by
-
Long-Term Protective Effects and Mechanisms of Gastric Bypass Surgery on the Kidneys in Hypertensive Obese Rat.Obes Surg. 2024 Apr;34(4):1257-1266. doi: 10.1007/s11695-024-07108-5. Epub 2024 Feb 23. Obes Surg. 2024. PMID: 38396260
-
Clinical validation of the terminological subset for people with chronic kidney disease undergoing conservative treatment.Rev Esc Enferm USP. 2024 Feb 12;57:e20230280. doi: 10.1590/1980-220X-REEUSP-2023-0280en. eCollection 2024. Rev Esc Enferm USP. 2024. PMID: 38358115 Free PMC article.
-
Temporal trends in hypertension related end stage renal disease mortality rates: an analysis of gender, race/ethnicity, and geographic disparities in the United States.Front Nephrol. 2024 Jan 15;3:1339312. doi: 10.3389/fneph.2023.1339312. eCollection 2023. Front Nephrol. 2024. PMID: 38288382 Free PMC article.
-
Isoliensinine Attenuates Renal Fibrosis and Inhibits TGF-β1/Smad2/3 Signaling Pathway in Spontaneously Hypertensive Rats.Drug Des Devel Ther. 2023 Sep 7;17:2749-2762. doi: 10.2147/DDDT.S414179. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 37701045 Free PMC article.
-
The trend of hypertension-related chronic kidney disease from 1990 to 2019 and its predictions over 25 years: an analysis of the Global Burden of Disease Study 2019.Int Urol Nephrol. 2024 Feb;56(2):707-718. doi: 10.1007/s11255-023-03707-w. Epub 2023 Aug 4. Int Urol Nephrol. 2024. PMID: 37542001
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical